Grace Rodriguez, CEO and executive director of Impact Hub Houston, and Jeff Reichman, founder of Sketch City, have announced a partnership between their organizations. Photos courtesy

Two Houston organizations that have partnered for three years to provide a platform for innovation and ideation have announced a more formalized partnership.

Impact Hub Houston, a global impact innovation incubator, and Sketch City, a nonprofit focused on advancing technology and data in public decision making and social good, have announced the merger of Sketch City into a new initiative under Impact Hub Houston: Code for Houston.

"We're honored to continue Sketch City's work of connecting Houston's tech talent with civic innovation opportunities through Code for Houston," says Grace Rodriguez, CEO and executive director of Impact Hub Houston, in a news release. "From our response and recovery collaboration after Hurricane Harvey to our ongoing events that help diverse do-gooders and developers collaborate on and create impactful solutions for Houston, we have established a strong track record of effective #Tech4Good initiatives."

The two organizations have worked together to host Open Project Night and the Houston Hackathon over the past few years. Jeff Reichman, principal at Houston-based data science consulting firm January Advisors, founded Sketch City in 2016.

"We are so excited to join forces with Impact Hub Houston," Reichman says in the release. "Their mission is directly aligned with ours. Sketch City began as a way to connect people with shared interests in technology, data, and civic improvement. Within a few years, it has grown into a community of thousands of people who live all over the world."

The merger comes following the impact of the COVID-19 pandemic — something Reichman says has led him to rethink how Sketch City operates.

"Merging Sketch City with Impact Hub Houston feels like a natural extension of the work we've done together; and it creates additional administrative capacity for programming and community growth," Reichman continues in the release. "Sketch City's efforts will continue under Impact Hub Houston's 'Code for Houston' initiative. I'm thrilled to be a part of that new chapter."

Sketch City and its initiatives will roll into Code for Houston, a new initiative under Impact Hub Houston that aligns with Code for America — a national organization that works with community organizations and governments to build digital tools, change policies, and improve public programs.

Code for Houston will streamline operations for Impact Hub Houston's annual hackathons, which includes the Houston Hackathon and Climathon Houston, as well as expand resources and support for Houston's changemakers and civic technologists who want to transform their ideas into viable triple-bottom-line businesses and impact ventures, per the release.

"We look forward to continuing Sketch City's legacy of strengthening and activating relationships between Houston's tech talent and diverse communities," Rodriguez continues.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.